Press Releases

July 25, 2019

As BlueBee expands commercial operations in the US, Pam Cheng joins the BlueBee management team to lead product strategy

San Mateo, CA, United States July 8, 2019 – BlueBee is pleased to announce the expansion of its senior management team with the appointment of Pam Cheng, Ph.D., as Vice President of Product Management and Strategy. Pam joins BlueBee with expertise in clinical bioinformatics honed from her years of experience at... Read more
March 6, 2019

Bluebee achieves Health Data Hosting (HDS) certification

Rijswijk, The Netherlands March 6, 2019 – BlueBee, a global bioinformatics solutions provider, has been awarded the HDS:2018 certification for its Information Security Management System (ISMS). The Hébergeurs de Données de Santé or Health Data Hosting (HDS) accreditation is required for entities hosting personal health data governed by French laws. The British... Read more
June 15, 2018

BlueBee Achieves ISO 13485 Medical Device Quality Standard Certification

Rijswijk, The Netherlands June 15, 2018 – BlueBee, a global bioinformatics solutions provider, has announced today that it has been awarded the ISO 13485:2016 certification. ISO 13485 is an internationally recognized medical device quality management systems standard, which was awarded to BlueBee for its design and development of software solutions and data... Read more
June 12, 2018

Lexogen and BlueBee Collaborate to Streamline QuantSeq-UMI Sequencing Data Analysis Pipeline

VIENNA, AUSTRIA, AND RIJSWIJK, THE NETHERLANDS, June 12, 2018 – Lexogen, a transcriptomics and next-generation sequencing company and BlueBee, a global bioinformatics platform, have announced today the implementation of QuantSeq Unique Molecular Identifiers (UMI) data analysis pipeline on the BlueBee genomics analysis platform. This collaboration offers QuantSeq users utilizing UMIs... Read more
May 16, 2018

BlueBee introduces BLUEBASE, a streamlined solution transforming data into actionable knowledge for clinical and translational genomics research

RIJSWIJK, THE NETHERLANDS, May 16, 2018 — BlueBee Corporation announced today the release of BLUEBASE, a complete data management solution designed to transform next-generation sequencing (NGS) and metadata into actionable genomic knowledge with efficiency and clinical-grade security. BLUEBASE runs on the BlueBee core data analysis platform and provides post-sequencing intelligent... Read more
February 8, 2018

New England Biolabs and BlueBee Partner to Deliver an End-To-End Data Analysis Solution for NEBNext Direct Target Enrichment

RIJSWIJK, The Netherlands & Ipswich, Massachusetts, USA — February 8, 2018 – BlueBee, a company driving global genomic data-driven medicine, and New England Biolabs, Inc. (NEB®) have partnered to provide a secure and convenient data processing solution for NEB’s NEBNext Direct target enrichment technology. Through this partnership, BlueBee enables NEB’s... Read more
December 19, 2017

Agendia and BlueBee Partner to Bring New NGS-Based MammaPrint® BluePrint® Breast Cancer Kit to Market

RIJSWIJK, NETHERLANDS and IRVINE, CA, AMSTERDAM, – 19 December 2017 – BlueBee, a company driving global genomic data-driven medicine, and Agendia, Inc, a world leader in personalized medicine and molecular cancer diagnostics, have partnered to provide a secure, convenient, data processing solution for Agendia’s MammaPrint BluePrint Breast Cancer Recurrence and... Read more
November 10, 2017

Lexogen and BlueBee Partner to Bring the SLAMseq Metabolic RNA Sequencing Data Analysis Pipeline to the Users

RIJSWIJK, The Netherlands and Vienna, Austria — November 10, 2017 — BlueBee, a company driving genomic data-driven medicine, and Lexogen a company enabling the analysis of the complete transcriptome, announce the successful integration of the SLAMdunk pipeline on BlueBee’s private cloud-based platform, making it available to analyze data generated by every... Read more
October 9, 2017

PACBIO AND BLUEBEE LAUNCH DE NOVO GENOME ASSEMBLY PIPELINE ON THE BLUEBEE ANALYSIS PLATFORM

RIJSWIJK, The Netherlands and MENLO PARK, Calif., — October 9th, 2017 — BlueBee, a company driving genomic data-driven medicine, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, announced they have integrated the PacBio® de novo assembly pipeline onto the BlueBee® genomics analysis platform. The integration creates... Read more
May 29, 2017

BlueBee and MediSapiens Announce Strategic Partnership

Read more
Request A Demo